WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
High-dose IV vitamin C plus chemotherapy found to double survival time in advanced pancreatic cancer

High-dose IV vitamin C plus chemotherapy found to double survival time in advanced pancreatic cancer

by Jennifer Brown,University of IowaGraphical abstract. Credit:Redox Biology(2024). DOI: 10.1016/j.redox.2024.103375Results from a randomized, phase 2 clinical trial show that adding
Oncology December 01,2024
High-dose IV vitamin C plus chemotherapy found to double survival time in advanced pancreatic cancer

High-dose IV vitamin C plus chemotherapy found to double survival time in advanced pancreatic cancer

by Jennifer Brown,University of IowaGraphical abstract. Credit:Redox Biology(2024). DOI: 10.1016/j.redox.2024.103375Results from a randomized, phase 2 clinical trial show that adding
Oncology December 01,2024
Mathematical modeling leads to a better understanding of prostate cancer

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine
Oncology December 01,2024
Mathematical modeling leads to a better understanding of prostate cancer

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine
Oncology December 01,2024
Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390
Oncology December 01,2024
Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390
Oncology December 01,2024
Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Oncology December 01,2024
Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Oncology December 01,2024
How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym
Oncology December 01,2024
How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym
Oncology December 01,2024
Drug combination prompts immune response in some resistant pancreatic cancers

Drug combination prompts immune response in some resistant pancreatic cancers

byJohns Hopkins University School of MedicineRadiologic scans and change in CA19.9 of the three responders during the course of entinostat plus nivolumab therapy. Credit:Nature Communicati
Oncology December 01,2024
Drug combination prompts immune response in some resistant pancreatic cancers

Drug combination prompts immune response in some resistant pancreatic cancers

byJohns Hopkins University School of MedicineRadiologic scans and change in CA19.9 of the three responders during the course of entinostat plus nivolumab therapy. Credit:Nature Communicati
Oncology December 01,2024
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
Oncology December 01,2024
How colliding genetic processes drive aggressive cancers

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch
Oncology December 01,2024
Report suggests a big improvement in lung cancer survival

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi
Oncology December 01,2024
Report suggests a big improvement in lung cancer survival

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi
Oncology December 01,2024
Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

byUniversity of TorontoCredit: Unsplash/CC0 Public DomainRegular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients
Oncology December 01,2024
Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

byUniversity of TorontoCredit: Unsplash/CC0 Public DomainRegular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients
Oncology December 01,2024
Salmonella research unlocks the potential of bacteria to treat bowel cancer

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w
Oncology December 01,2024
Salmonella research unlocks the potential of bacteria to treat bowel cancer

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w
Oncology December 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com